Stockscreener 앱 받기
10.37
1.57%
0.16
전일 마감가:
$10.21
열려 있는:
$10.21
하루 거래량:
529.58K
Relative Volume:
0.66
시가총액:
$359.84M
수익:
$2.07M
순이익/손실:
$-47.68M
주가수익비율:
-3.6773
EPS:
-2.82
순현금흐름:
$-31.31M
1주 성능:
+0.29%
1개월 성능:
+3.39%
6개월 성능:
-7.82%
1년 성능:
-24.14%
1일 변동 폭
$10.08
$10.64
1주일 범위
$10.00
$10.64
52주 변동 폭
$8.12
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
명칭
Delcath Systems Inc
전화
(518) 743-8892
주소
566 QUEENSBURY AVENUE, QUEENSBURY, NY
DCTH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
10.37 | 354.29M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-28 | 개시 | Craig Hallum | Buy |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2022-07-26 | 재개 | Canaccord Genuity | Buy |
| 2021-12-10 | 개시 | H.C. Wainwright | Buy |
| 2021-03-09 | 개시 | Canaccord Genuity | Buy |
| 2021-01-05 | 개시 | BTIG Research | Buy |
| 2020-06-01 | 개시 | Laidlaw | Buy |
모두보기
Delcath Systems Inc 주식(DCTH)의 최신 뉴스
Is Delcath Systems Inc backed by strong institutional buyingLong Setup & Daily Growth Stock Investment Tips - baoquankhu1.vn
Market Catalysts: Is ODYS forming a bullish divergenceEarnings Performance Report & Real-Time Buy Signal Notifications - baoquankhu1.vn
Price-Driven Insight from (DCTH) for Rule-Based Strategy - Stock Traders Daily
Delcath Systems expects FY revenue of $85.2 million - MSN
Delcath Systems: Stabilizing Fundamentals Justify A Rating Upgrade (NASDAQ:DCTH) - Seeking Alpha
Delcath Systems Reports Strong Preliminary 2025 Results - TipRanks
NY-based Delcath Systems expects Q4 2025 revenue to hit USD 20.7M - Medical Buyer
Aug Closing: Is Delcath Systems Inc subject to activist investor interestJuly 2025 Institutional & Target Return Focused Stock Picks - baoquankhu1.vn
Delcath Systems, Inc. (NASDAQ:DCTH) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Delcath Systems, Inc. (NASDAQ:DCTH) Q2 2025 Earnings Call Transcript - MSN
EBITDA per share of Delcath Systems, Inc. – DUS:DV3R - TradingView — Track All Markets
Delcath reports $85.2 million in 2025 revenue, strong cash position By Investing.com - Investing.com Nigeria
Delcath Systems (NASDAQ:DCTH) Stock Rating Upgraded by Wall Street Zen - MarketBeat
DCTH FinancialsIncome Statement - Quiver Quantitative
DCTH: HC Wainwright Reiterates Buy Rating with $30 Price Target - GuruFocus
HC Wainwright Reaffirms Buy Rating for Delcath Systems (NASDAQ:DCTH) - MarketBeat
Delcath Systems, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2025 - MarketScreener
Delcath Systems (DCTH) Exceeds Revenue Expectations in Q4 and Fu - GuruFocus
Delcath Systems announces preliminary fourth quarter and full year 2025 financial results - marketscreener.com
Delcath reports $85.2 million in 2025 revenue, strong cash position - Investing.com
Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results - The AI Journal
Will Delcath Systems Inc. stock outperform Nasdaq indexWeekly Market Report & Fast Entry Momentum Alerts - ulpravda.ru
ETF Watch: Will Delcath Systems Inc. stock remain a Wall Street favoriteTrade Ideas & Reliable Price Breakout Signals - Улправда
How resilient is Delcath Systems Inc. stock in market downturnsJuly 2025 Retail & Weekly Top Gainers Alerts - ulpravda.ru
Will Delcath Systems Inc. stock remain a Wall Street favoriteMarket Volume Summary & Daily Technical Forecast Reports - Улправда
Shorts Report: Will Delcath Systems Inc stock remain a Wall Street favorite2025 Earnings Impact & Daily Growth Stock Investment Tips - Bộ Nội Vụ
Delcath Systems, Inc. (DCTH) Beats Q4 Earnings and Revenue Estimates - MSN
A Look At Delcath Systems (DCTH) Valuation After New Phase 3 FOCUS Subgroup Data On HEPZATO KIT - Sahm
Under the Radar: 3 Microcap Growers Passing a Tough Test - Benzinga
Will Delcath Systems Inc. stock sustain high P E ratios2026 world cup usa national team round of 16 key players high defensive line match prediction expert opinion - Улправда
Will New HEPZATO KIT Subgroup Data on Tumor Burden and Survival Change Delcath Systems' (DCTH) Narrative - Sahm
(DCTH) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Should New HEPZATO Subgroup Data and Delcath’s Targeted Strategy Require Action From DCTH Investors? - Yahoo Finance
Are options traders betting on a big move in Delcath Systems stock? - MSN
Delcath Systems Inc Stock Analysis and ForecastLong-Term Growth Stocks & Fast Growing Investment Plans - earlytimes.in
Hepzato Kit Safe, Effective in Metastatic, Unresectable Uveal Melanoma - Cure Today
Are Options Traders Betting on a Big Move in Delcath Systems Stock? - Nasdaq
Delcath Systems publishes results from subgroup analyses of FOCUS study - Yahoo Finance
Delcath’s HEPZATO shows consistent efficacy across patient subgroups By Investing.com - Investing.com Nigeria
Delcath Systems (DCTH) Reveals Key Findings from FOCUS Study Sub - GuruFocus
Delcath’s HEPZATO shows consistent efficacy across patient subgroups - Investing.com
Which metastatic uveal melanoma patients gain most from a liver-directed drug? - Stock Titan
Simplify Asset Management Inc. Increases Stock Position in Delcath Systems, Inc. $DCTH - MarketBeat
Glenmark Pharmaceuticals Limited (532296) Gets Regulatory ApprovalFibonacci Extensions & Build Wealth With Strategy - bollywoodhelpline.com
Book value per share of Delcath Systems, Inc. – MUN:DV3R - TradingView — Track All Markets
Bearish Setup: Is Delcath Systems Inc stock a smart buy before Fed meetingTrade Entry Summary & Advanced Technical Signal Analysis - Bộ Nội Vụ
Precision Trading with Delcath Systems Inc. (DCTH) Risk Zones - Stock Traders Daily
Delcath Systems, Inc. (NASDAQ:DCTH) is a favorite amongst institutional investors who own 51% - Yahoo Finance
Delcath Systems (STU:DV3R) EV-to-OCF : 19.88 (As of Dec. 21, 2025) - GuruFocus
Why Delcath Systems Inc. (DV3R) stock stays on buy lists2025 Biggest Moves & Entry Point Strategy Guides - bolumsonucanavari.com
Delcath Systems Earnings Notes - Trefis
Delcath Systems Inc (DCTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
1.96%
자본화:
|
볼륨(24시간):